Vycor Medical (VYCO) Cash from Investing Activities (2010 - 2026)
Vycor Medical (VYCO) posted quarterly Cash from Investing Activities of $2140.0 for Q1 2026, up 233.25% quarter-over-quarter from -$1606.0 in Q4 2025.
Vycor Medical (VYCO) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Cash from Investing Activities for 17 consecutive years, with $2140.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to $2140.0; the TTM figure through Mar 2026 stood at $704.0 (changed N/A YoY), while the FY2025 annual figure was -$4383.0, down 4.38% from the prior year.
- Cash from Investing Activities advanced to $2140.0 in Q1 2026 per VYCO's latest filing, from -$1606.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $2140.0 in Q1 2026 and bottomed at -$5904.0 in Q4 2023.
- Historically, Cash from Investing Activities has averaged -$1148.5 across 5 years, with a median of $170.0 in 2024.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities slumped 4291.67% — and 2024, when it jumped 129.86%.
- Vycor Medical's Cash from Investing Activities stood at $322.0 in 2022, then tumbled by 1933.54% to -$5904.0 in 2023, then surged by 102.88% to $170.0 in 2024, then slumped by 1044.71% to -$1606.0 in 2025, then jumped by 233.25% to $2140.0 in 2026.
- Business Quant data shows VYCO's Cash from Investing Activities at $2140.0 in Q1 2026, -$1606.0 in Q4 2025, and $170.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 342.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,140.00 |
| Mar 31, 2026 | 2,140.00 |
| Dec 31, 2025 | -1,606.00 |
| Dec 31, 2025 | -1,606.00 |
| Dec 31, 2024 | 170.00 |
| Dec 31, 2024 | 170.00 |
| Sep 30, 2024 | -5,031.00 |
| Sep 30, 2024 | -5,031.00 |
| Mar 31, 2024 | 662.00 |
| Mar 31, 2024 | 662.00 |
| Dec 31, 2023 | -5,904.00 |
| Dec 31, 2023 | -5,904.00 |
| Sep 30, 2023 | -4,024.00 |
| Sep 30, 2023 | -4,024.00 |
| Jun 30, 2023 | 254.00 |
| Jun 30, 2023 | 254.00 |
| Mar 31, 2023 | 288.00 |
| Mar 31, 2023 | 288.00 |
| Dec 31, 2022 | 322.00 |
| Dec 31, 2022 | 322.00 |